385 related articles for article (PubMed ID: 21348544)
1. Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study.
Fabbrocini G; Staibano S; De Rosa G; Battimiello V; Fardella N; Ilardi G; La Rotonda MI; Longobardi A; Mazzella M; Siano M; Pastore F; De Vita V; Vecchione ML; Ayala F
Am J Clin Dermatol; 2011 Apr; 12(2):133-41. PubMed ID: 21348544
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of acne.
Toyoda M; Morohashi M
Med Electron Microsc; 2001 Mar; 34(1):29-40. PubMed ID: 11479771
[TBL] [Abstract][Full Text] [Related]
3. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
4. A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris.
Gold MH
J Drugs Dermatol; 2006 May; 5(5):442-5. PubMed ID: 16703780
[TBL] [Abstract][Full Text] [Related]
5. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris.
Fadel M; Salah M; Samy N; Mona S
J Drugs Dermatol; 2009 Nov; 8(11):983-90. PubMed ID: 19894365
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne.
Angelova-Fischer I; Rippke F; Fischer TW; Neufang G; Zillikens D
J Eur Acad Dermatol Venereol; 2013 Jul; 27 Suppl 2():6-11. PubMed ID: 23731195
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence photography in the evaluation of acne.
Lucchina LC; Kollias N; Gillies R; Phillips SB; Muccini JA; Stiller MJ; Trancik RJ; Drake LA
J Am Acad Dermatol; 1996 Jul; 35(1):58-63. PubMed ID: 8682965
[TBL] [Abstract][Full Text] [Related]
8. Acne: a new model of immune-mediated chronic inflammatory skin disease.
Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
Lucky A; Jorizzo JL; Rodriguez D; Jones TM; Stewart DM; Tschen EH; Kanof NB; Miller BH; Wilson DC; Loven KH
Cutis; 2001 Oct; 68(4 Suppl):34-40. PubMed ID: 11845946
[TBL] [Abstract][Full Text] [Related]
10. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
11. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
[TBL] [Abstract][Full Text] [Related]
12. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
[TBL] [Abstract][Full Text] [Related]
13. Cosmeceuticals based on Rhealba(®) Oat plantlet extract for the treatment of acne vulgaris.
Fabbrocini G; Saint Aroman M
J Eur Acad Dermatol Venereol; 2014 Dec; 28 Suppl 6():1-6. PubMed ID: 25428278
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
15. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study.
Jahns AC; Lundskog B; Ganceviciene R; Palmer RH; Golovleva I; Zouboulis CC; McDowell A; Patrick S; Alexeyev OA
Br J Dermatol; 2012 Jul; 167(1):50-8. PubMed ID: 22356121
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action.
Hörfelt C; Stenquist B; Larkö O; Faergemann J; Wennberg AM
Acta Derm Venereol; 2007; 87(4):325-9. PubMed ID: 17598035
[TBL] [Abstract][Full Text] [Related]
17. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
[No Abstract] [Full Text] [Related]
18. Newer approaches in topical combination therapy for acne.
Fu LW; Vender RB
Skin Therapy Lett; 2011 Oct; 16(9):3-6. PubMed ID: 22089505
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study.
Villani A; Annunziata MC; Cinelli E; Donnarumma M; Milani M; Fabbrocini G
G Ital Dermatol Venereol; 2020 Oct; 155(5):676-679. PubMed ID: 32869963
[TBL] [Abstract][Full Text] [Related]
20. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
